Headlands Research, Inc. and its subsidiaries (“Headlands”, “we”, or “us”) knows that you value your privacy. We are a clinical trial site network conducting clinical trials for pharmaceutical companies. This Privacy Policy explains the information we collect through the websites available via www.Headlandsresearch.com and other Headlands managed websites or services that include an authorized link or reference to this Privacy Policy (collectively, the “Services”). By using the Headlands Services, you consent to the data practices described in this statement.
We collect the following categories of information when you access or use the Services, which may be considered personal information when maintained in identifiable form.
We may also collect information from other sources in accordance with applicable law. For example, we may collect information that you have authorized your health care provider to share with us. Information that is collected when you use the Services may be combined with other information collected from you or other sources.
We may aggregate or de-identify the information described above. Aggregated or de-identified data is not subject to this Privacy Policy.
We use and otherwise process each of the categories of information identified above for the following business purposes:
Headlands generally does not sell, rent or lease its customer lists to third parties. However, we may share your information with the following third parties:
When you use the Services, we and our third-party analytics and advertising partners may use cookies, pixel tags, and other similar technologies (collectively, “cookies”) to collect information about your browser and use of the Services. This helps us, for example, measure and understand how visitors interact with the online Services and our content, deliver customized content, and improve the Services. By using the Services, you consent to our use of cookies and similar technologies. Please consult your browser settings and mobile settings for choices that may be available to you to limit cookies. Depending on your settings, you may not be able to take advantage of all of the features of the Services.
The following types of cookies are used on the Services:
You may be able to refuse or disable cookies by adjusting your web browser settings. Some browsers have options that allow the visitor to control whether the browser will accept cookies, reject cookies, or notify the visitor each time a cookie is sent. Because each web browser is different, please consult the instructions provided by your web browser (typically in the “help” section). Please note that you may need to take additional steps to refuse or disable Local Shared Objects and similar technologies. For example, Local Shared Objects can be controlled through the instructions on Adobe’s Setting Manager page. If you choose to refuse, disable, or delete these technologies, some of the functionality of the Services may no longer be available to you and any differences in service are related to the data. Deleting cookies may in some cases cancel the opt out selection in your browser.
Some of our third-party partners are members of the Network Advertising Initiative, which offers a single location to opt out of ad targeting from member companies. To learn more, please click here or here. For additional information on how Google processes your information and what choices you may have, visit their site here.
Do-Not-Track Signals and Similar Mechanisms. Some mobile and web browsers transmit "do-not-track" signals. Because of differences in how web browsers incorporate and activate this feature, it is not always clear whether users intend for these signals to be transmitted, or whether they even are aware of them. We currently do not take action in response to these signals.
The Services may contain links to other third-party websites, which may be able to collect information about you. Please be aware that we are not responsible for the content or privacy practices of such third-party websites. We encourage our users to be aware when they leave our Services and to read the privacy statements of any other website that collects personally identifiable information.
You may be entitled, in accordance with applicable law, to request access to or deletion of your information or more information about our information practices. To submit a data access or data deletion request, please contact us at Privacy@headlandsresearch.com.
Please note that you must verify your identity and request before Headlands will process your request. You may be required to provide email confirmation or other information in order for us to verify your identity. We will not discriminate against you for exercising your rights and choices, although some of the functionality and features available on the Services may change or no longer be available to you.
Under certain circumstances, you may designate an authorized agent to make a request on your behalf. In order to designate an authorized agent to make a request on your behalf, you must provide a valid power of attorney, your valid government issued identification, and the authorized agent’s valid government issued identification to allow Headlands to verify that the agent is authorized to make the request on your behalf.
Headlands does not knowingly collect personally identifiable information from children under the age of thirteen through its online Services. If we learn that a child has provided us with personal information, we will delete it or otherwise comply with applicable law.
From time to time, Headlands may contact you via email for the purpose of providing announcements, promotional offers, alerts, confirmations, surveys, and/or other general communication. In order to improve our Services, we may receive a notification when you open an email from Headlands or click on a link therein.
You may also opt into marketing or promotional communications through the Services. If you would like to stop receiving marketing or promotional communications via email from Headlands, you may opt out of such communications by clicking an unsubscribe link that is included in emails sent when we use a third party email service, or replying to the email requesting to be removed from our list.
We take reasonable steps to protect your information from unauthorized access. You should keep in mind, however, that no internet transmission is ever 100% secure or error free. In particular, email sent to or from this web site or online resource may not be secure, and you should therefore take special care in deciding what information you send to us via email.
Headlands is a U.S. company, and your communication with us may result in the transfer of information across international boundaries, including to U.S. law enforcement. By using this site, you consent to the collection, storage, and processing of your information outside your jurisdiction of residence.
Headlands reserves the right to change this Privacy Policy from time to time. We will notify you about significant changes in the way we treat personal information by placing a prominent notice on our website, and/or by updating any privacy information on this page. Your continued use of the Services after such modifications will constitute your: (a) acknowledgment of the modified Privacy Policy; and (b) agreement to abide and be bound by that Policy.
Headlands welcomes your questions or comments regarding this Privacy Policy. If you believe that Headlands has not adhered to this Privacy Policy, please contact Headlands at:
Email Address:
privacy@headlandsresearch.com
Effective as of December 15, 2020
"*" indicates required fields
Alissa is a board-certified family nurse practitioner with extensive experience in clinical research across pediatric, adolescent, and adult populations. As an Investigator at PRA, she leverages her expertise to support diverse areas of clinical trials to support advancements in healthcare.
Alissa is a graduate of the University of California, Los Angeles where she completed her Master of Science in Nursing. In addition, she holds a Bachelor of Science in Nursing from California State University, San Marcos and a Bachelor of Science in Animal Physiology & Neuroscience from the University of California, San Diego. Her professional experience includes Emergency Medicine, Critical Care, Infectious Diseases, Primary Care, Women’s Health and Research Drug and Development. When she isn’t working, she is traveling, cooking, reading, watching movies, or spending time with loved ones (including her cat).
Paige began working as a clinical research coordinator at Peninsula Research Associates in 2020. Since joining our team, she has worked on various clinical trials, including COVID-19 antibody treatment studies, a phase II recombinant protein COVID-19 vaccine study, a phase I mRNA COVID-19 vaccine study and a phase III pneumococcal vaccine study. Paige is passionate about helping patients receive quality healthcare through clinical research.
Paige graduated from Chapman University with a bachelor’s degree in health science. During her undergraduate studies, Paige worked as a clinical research intern in the Czech Republic and as a patient experience intern at UCI medical center.
Contact Paige at:
Office: 310-265-1623 x312
Paige.Endo@PeninsulaResearch.com
Kristen joined the PRA team as a clinical research coordinator in 2018. She primarily works with Oral Immunotherapy (OIT) food allergy trials, including peanut and egg allergy studies. Her study on Palforzia just got approved by the FDA! She will soon be leading a study involving OIT multi-food allergies. Additionally, Kristen’s areas of research include asthma, atopic dermatitis, COVID-19 vaccines, COVID-19 antibody treatments, and pneumococcal vaccines.
he brings her cheery attitude from working as a Summer Camp Counselor to PRA. Her expertise and love for working with children shines through in her patient interactions.
Outside of work, Kristen enjoys playing soccer and spending time with her family.
Contact Kristen at:
Office: 310-265-1623 x317
Kristen.Currie@PeninsulaResearch.com
Heather has been working as a clinical research coordinator at Peninsula Research Associates since 2017. She currently devotes her time to PRA’s phase III trials, focusing primarily on asthma, atopic dermatitis and diabetes studies. Heather helps maintain a high level of patient care while ensuring our research goals are being met.
Heather earned her bachelor’s degree in psychology and business from Humboldt State University. She is currently working towards becoming a nurse practitioner.
Contact Heather at:
Office: 310-265-1623 x302
Heather.Mendoza@PeninsulaResearch.com
Monika manages the research coordinators and research assistants at Peninsula Research Associates. She also currently works on PRA’s trials in the following areas; COVID-19 and non-COVID-19 Vaccines, COVID-19 Monoclonal Antibodies, Quality of Life/Exercise Capacity asthma, atopic dermatitis and eosinophilic esophagitis. She helps the PRA team maintain a high level of patient care while ensuring our research goals are being met.
Monika earned her bachelor’s degree in BioPsychology from Tufts University. After graduation, she gained experience in venipuncture and injections as a veterinary technician. She also worked in the financial sector as a project manager and managing a start-up. Monika then moved into the pharmaceutical research industry, working for many years for the pharmaceutical company, Theravance. There, she worked primarily in the Drug Metabolism PharmacoKinetics Department, running in-vivo and in-vitro studies for novel compounds. Monika played a key role in this department, facilitating the advancement of many of those novel compounds through pre-clinical research to FDA approval for clinical trials. She brings the combination of her management skills and medical background to help meet PRA’s research goals.
Monika is very excited for this opportunity of working with the strong members that make up the PRA team and to maintain the superior level of research Peninsula Research Associates is known for.
Contact Monika at:
Office: 310-265-1623 x228
Monika.LaraLin@PeninsulaResearch.com
Debbie Cappy began working with Dr. Sher in 1991 and has played a key role in over 300 clinical research trials. Debbie’s areas of expertise include allergic rhinitis, asthma, attention-deficit/hyperactivity disorder, autism, chronic obstructive pulmonary disease, diabetes, hypercholesterolemia, infectious diseases, otitis media, pain management, sleep disorders, vaccinations, women’s health, and, most recently, COVID-19 vaccinations and treatments.
Debbie works very closely with the IRB, IBC, sponsors, monitors, and FDA Inspectors. She ensures that ICH/GCP guidelines are followed in hopes that new, safe and effective medications and therapies will become available to the general public.
Debbie received her clinical research coordinator certification from the Association of Clinical Research Professionals (ACRP) in 2006. Debbie continues her clinical research education with ACRP, NIH, and the National Health & Safety Association.
Contact Debbie at:
Office: 310-265-1623 x301
Debbie.Cappy@PeninsulaResearch.com
As Chief Financial Officer, Renée manages all cost, managerial, and financial accounting for Peninsula Research Associates. She is responsible for the day-to-day administration of accounts receivable, accounts payable, payroll, benefits, and human resources. In addition to assisting management with important financial decisions, Renée also prepares forecasts, budgets, and financial statements. Renée’s expertise includes determining ways to reduce costs and meeting the legal requirements to keep the financial state of Peninsula Research Associates in good standing.
Renée has been with PRA since 2015 and brought with her a plethora of knowledge and experience of the healthcare industry and financial decision support.
Renée enjoys cooking and traveling with her husband and two children.
Contact Renée at:
Office: 310-265-1623 x310
Renee.Goldstein@PVMedGroup.com
Leigh Ann is a board licensed family nurse practitioner. She serves as a research sub-investigator for many of our studies at Peninsula Research Associates. Her primary focus is on food allergy treatments, eczema, asthma and COVID-19 vaccines and treatments.
Leigh Ann also provides primary care services to a wide range of patients at Palos Verdes Medical Group (PVMG), a multi-specialty private practice associated with PRA.
Leigh Ann completed her Master of Science in Nursing (MSN) at the University of Southern California. She also attended Mount St.. Mary’s College of Nursing as well as Marymount College in Rancho Palos Verdes. Leigh Ann’s experience includes working as an ED nurse, charge nurse, trauma coordinator and home health care nurse.
Leigh Ann is a South Bay native and is loving the fact that she is able to work and raise her family in the same community that she grew up in.
Contact Leigh Ann at:
Office: 310-265-1623
LeighAnn.Schmidt@pvmedgroup.com
Dr. Sher completed his medical degree at the University of Utah School of Medicine (1983) and residency in pediatrics (1987) and fellowship in allergy and immunology at the University of California Los Angeles.
He is board certified by the American Board of Pediatrics and American Board of Allergy and Immunology. He is a fellow with the American Academy of Pediatrics; American College of Allergy, Asthma, and Immunology; and American Academy of Allergy, Asthma, & Immunology.
Since founding Peninsula Research Associates (PRA) in 1999, Dr. Sher has been the PI for over 200 clinical trials for conditions such as allergic rhinitis, asthma, ADHD, COPD, hypertension, otitis media, pneumonia, and sinusitis. Many of these trials have contributed to new medications and devices in the market.
Dr. Sher continues to work as a physician at Palos Verdes Medical Group, a multispecialty practice and urgent care center encompassing pediatric care; ADHD; internal medicine; and adult and pediatric asthma, allergy, and immunology. Dr. Sher has been practicing in Rolling Hills Estates for the past 25 years.
Dr. Sher stays involved in the community in programs such as the Los Angeles County School Nurses Association and Food Allergy and Anaphylaxis Network, where he is currently the Medical Chair for the South Bay region. He has also been appointed to serve on several national committees for the American Academy of Allergy, Asthma, & Immunology and American College of Allergy, Asthma, and Immunology including the Specific IgE Task Force, Immunotherapy and Allergy Diagnostics Committee, and Rhinitis and Sinusitis Committee.
Dr. Sher has published articles in numerous medical journals, including the Pediatric Infectious Disease Journal; Clinical Infectious Disease; Clinical Therapeutics; and Annals of Allergy, Asthma & Immunology. He authored “Diagnosing Allergic Diseases: Why Knowing the History is as Important as the Test,” published in Contemporary Pediatrics, and co-authored “Community-based Treatment of Acute Uncomplicated Bacterial Rhinosinusitis with Gatifloxacin,” “Safety and Efficacy of Gatifloxacin Therapy for Children with Recurrent Acute Otitis Media (AOM) and/or AOM Treatment Failure,” and “Pearls and Pitfalls of Allergy Diagnostic Testing: Report from the American College of Allergy, Asthma, and Immunology/American Academy.
Click here for a list of publications and features of Dr. Lawrence Sher’s.